Carlumab

Tax included
Carlumab (CNTO 888) is a humanised anti-CCL2 (chemokine ligand 2) antibody with high affinity. Carlumab can be used in cancer research, particularly in prostate cancer.
MedChemExpress 
HY-P99188

Data sheet

Size
Multiple sizes
Reactivity
CCR
Application
Cancer-programmed cell death
CAS
915404-94-3